Evening Primrose Oil or other essential fatty acids for the treatment of pre-menstrual syndrome (PMS)

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Wang, Wei ^a   Chen, H ^b   Liu, J ^b  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; GAMMA LINOLENIC ACID; PLACEBO; PRIMROSE OIL;

CLINICAL TRIAL; DATA ANALYSIS; DRUG INDUCED HEADACHE; EPILEPSY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEALTH HAZARD; HUMAN; OUTCOME ASSESSMENT; PREMENSTRUAL SYNDROME; REVIEW; SCORING SYSTEM; STATISTICAL ANALYSIS; SYMPTOM;

EID: 44949207639     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD001123.pub3     Document Type: Review

References (14)

1. BNF 1996 British Medical Association. British National Formulary. Bath: The Bath Press, 1996.
2. Brush 1984 Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. American Journal of Obstetrics and Gynaecology 1984;150(4):363-6.
3. Budeiri 1996 Budeiri D, Li Wan Po A, Dornan JC. Is Evening Primrose Oil of value in the treatment of PMS. Controlled Clinical Trials 1996;17:60-8.
4. Daugherty 1998 Daugherty JE. Treatment strategies for premenstrual syndrome. American Family Physician 1998;58(1):183-92, 197-8.. [MEDLINE: 9672437].
5. Dickerson 2003 Dickerson LM, Mazyck PJ, Hunter MH. Premenstrual syndrome. American Family Physician 2003;67(8):1743-52. [MEDLINE: 12725453].
6. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(7109):629-34. [MEDLINE: 9310563].
7. Foster 1999 Foster S, Tyler VE. Tyler's Honest Herbal. American Journal of Pharmaceutical Education, 1999.
8. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. BMJ 2003;327(7414):557- 60. [MEDLINE: 12958120].
9. Horrobin 1983 Horrobin DF. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. Journal of Reproductive Medicine 1983;27(7):465-8.
10. Horrobin 1989 Horrobin DF, Manku MS. Premenstrual syndrome and premenstrual breast pain: disorders of essential fatty acid (EFA) metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids Review 1989;37:255-61.
11. Kleijnen 1994 Kleijnen J. Evening primrose oil. BMJ 1994;309:824-5.
12. Phinney 1994 Phinney S. Potential risk of prolonged gamma-linolenic acid use. Annals of Internal Medicine 1994;120(8):692.
13. Sampalis 2003 Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Alternative Medicine Review 2003;8(2):171-9.. [MEDLINE: 12777162].
14. Vaddadi 1981 Vaddadi KS. The use of gamma-linoleic acid and linoleic acid to differentiate between temporal lobe epilepsy and schizophrenia. Prostaglandins and Medicine 1981;6(4):375-9.